Subsequent Events	6 Months Ended
Jun. 30, 2025
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Management has evaluated subsequent events for potential recognition or disclosure in these condensed consolidated financial statements through August 8, 2025, which was the date the condensed consolidated financial statements were available to be issued. iPO Proceeds Effective October 30, 2024, the Company’s latest offering statement was qualified by the SEC. Since the report date through the date of this filing, we have raised approximately $1.3 million from settled subscriptions. Tax Legislation Changes On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was signed into law, which makes permanent many of the tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act that were set to expire at the end of 2025, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The Company is currently evaluating the potential impacts of the OBBBA; however, it is not expected to have a material impact on the Company’s condensed consolidated financial statements.

Subsequent Events

6 Months Ended

Jun. 30, 2025

Management has evaluated subsequent events for potential recognition or disclosure in these condensed consolidated financial statements through August 8, 2025, which was the date the condensed consolidated financial statements were available to be issued.

iPO Proceeds

Effective October 30, 2024, the Company’s latest offering statement was qualified by the SEC. Since the report date through the date of this filing, we have raised approximately $1.3 million from settled subscriptions.

Tax Legislation Changes

On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was signed into law, which makes permanent many of the tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act that were set to expire at the end of 2025, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The Company is currently evaluating the potential impacts of the OBBBA; however, it is not expected to have a material impact on the Company’s condensed consolidated financial statements.